ABSTRACT Twenty patients with inoperable carcinoma in the trachea or a main bronchus were investigated before and one and 10 days after treatment with a carbon dioxide laser. Patients were assessed by spirometry, maximum flow-volume loops, and a visual analogue score of breathlessness on a scale from 0 (not at all breathless) to 100 (very breathless). At day 10 mean FEV, had improved from 51-9% to 62-6% of predicted (p < 0-02) and mean peak expiratory flow (PEF) from 45-3% to 53-1% of the predicted value (p < 0 05). Improvements in maximum inspiratory and expiratory flows at 50% vital capacity were not significant but the breathlessness score decreased from a mean of 49 1 to 35 3 (p < 0 01). Improvements in breathlessness were significantly correlated with increases in FEV, and PEF. Thirteen of the 20 patients had unilateral tumours with partial or complete occlusion of the main bronchus; in these perfusion and ventilation were assessed by radioisotope scans before and 10 days after treatment. Seven of the 13 patients showed an increase in perfusion of the affected lung after treatment but the improvement was small, with a mean increase in unilateral perfusion in the 13 patients of 2-4% of the total counts. Four patients with no perfusion of the affected side showed no significant improvement after laser treatment. Changes in ventilation scans were similar to those in perfusion. It is concluded that laser treatment improves airway function and dyspnoea in malignant narrowing of central airways and that in unilateral obstruction such treatment results, at best, in a small increase in the contribution of the affected lung to perfusion. 
ABSTRACT Twenty patients with inoperable carcinoma in the trachea or a main bronchus were investigated before and one and 10 days after treatment with a carbon dioxide laser. Patients were assessed by spirometry, maximum flow-volume loops, and a visual analogue score of breathlessness on a scale from 0 (not at all breathless) to 100 (very breathless). At day 10 mean FEV, had improved from 51-9% to 62-6% of predicted (p < 0-02) and mean peak expiratory flow (PEF) from 45-3% to 53-1% of the predicted value (p < 0 05). Improvements in maximum inspiratory and expiratory flows at 50% vital capacity were not significant but the breathlessness score decreased from a mean of 49 1 to 35 3 (p < 0 01). Improvements in breathlessness were significantly correlated with increases in FEV, and PEF. Thirteen of the 20 patients had unilateral tumours with partial or complete occlusion of the main bronchus; in these perfusion and ventilation were assessed by radioisotope scans before and 10 days after treatment. Seven of the 13 patients showed an increase in perfusion of the affected lung after treatment but the improvement was small, with a mean increase in unilateral perfusion in the 13 patients of 2-4% of the total counts. Four patients with no perfusion of the affected side showed no significant improvement after laser treatment. Changes in ventilation scans were similar to those in perfusion. It is concluded that laser treatment improves airway function and dyspnoea in malignant narrowing of central airways and that in unilateral obstruction such treatment results, at best, in a small increase in the contribution of the affected lung to perfusion. technically satisfactory flow-volume loops.5 Each measurement was expressed as a percentage of predicted normal on the basis of standard regression equations.5 6 Breathlessness was assessed by using a 100mm visual analogue scale marked "not at all breathless" (0) at one end and "very breathless" (100) at the other.
Laser resection was performed under general anaesthesia by one operator (GNM) with a carbon dioxide laser and forceps through a modified rigid bronchoscope. As much tumour as could safely be removed was resected in a single session. Seven patients were taking prednisolone at the time of laser treatment and all patients were given dexamethasone during induction of anaesthesia.
Functional assessment was performed before, the day after, and 10 days after laser treatment.
Thirteen of the 20 patients had unilateral disease and in these patients relative perfusion and ventilation of each lung was assessed by radioisotope scanning, with 99mTc and 133Xe respectively, before and 10 days after treatment. The seven patients (Nos 1-7) with disease limited to the trachea did not have lung scans.
The contribution of the affected lung to total perfusion was calculated by computer from the average counts obtained in both posteroanterior and anteroposterior views and expressed as perfusion counts from affected lung x 100 perfusion counts from both lungs
In patients 8-12 the contribution of the diseased lung to total ventilation was assessed qualitatively from the initial full inhalation scan. In patients 13-20 the contribution to ventilation from the affected side was assessed quantitatively from the inhalation scan and expressed as ventilation counts from affected lung x 100 ventilation counts from both lungs Differences before and after treatment were examined by means of paired t-tests. Differences between patients with lesions in the trachea (Nos 1-7) and those with tumour in either main bronchus were examined by means of unpaired t-tests.
Results
All the patients had some degree of airflow limitation before treatment, with a mean FEV1 of 5911% of the predicted value (table 1). The changes in the chest radiograph and lung scan (in patients 8-20) after treatment are shown in table 2. The changes in functional data at day 1 are shown in figure 1 and at day 10 in figure 2. DAY 1 Changes in function were variable and only the change in FEV1 was significant (p < 0 05; fig 1) . Only eight patients recorded a symptomatic improvement on day 1 by the visual analogue scale scores and the remaining 12 showed a deterioration. In six patients (Nos 3, 4, 6, 8, 10, 14) the chest radiograph showed partial or complete re-expansion of a collapsed lung or lobe. In the other 14 the radiograph was unchanged (table 2). Of the 13 perfusion scans obtained before treatment, four (Nos 9, 13, 14, 17) showed no apparent perfusion of the affected lung; in three of these cases the pretreatment radiograph showed complete or partial collapse of the ipsilateral lung and the fourth patient (No 13) has a hilar mass. Ten days after treatment only one of these four patients (No 13) showed any evidence of perfusion to the affected side, and in this subject the post-treatment contribution of the diseased side was only 4% of the total perfusion. Two patients (Nos 18 8 who showed no improvement in tests of airway function in nine patients with tumours in main or lobar bronchi six weeks after radiotherapy. By contrast, Fazio et al9 reported substantial improvement in ventilation and perfusion scans after radiotherapy for central carcinomas. The improvements in perfusion were larger than we found but nearly half of their patients had small cell lung cancer, which is more responsive to radiotherapy than are other histological types. A direct comparison of laser resection and radiotherapy in a previously untreated group of patients with central tumours would therefore be worthwhile.
In conclusion, we have found that laser treatment improves airway function and lessens breathlessness in patients with tumours in the trachea or either main bronchus. In unilateral disease changes in perfusion of the affected lung were variable and usually small. We did not, however, find any evidence to suggest that improvements in ventilation after laser treatment would lead to a disadvantageous increase in deadspace.
